This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by BARBARINO, A. Articles by BARINI, A. Search for Related Content PubMed PubMed Citation Articles by BARBARINO, A. Articles by BARINI, A.

Corticotropin-Releasing Hormone Inhibition of Gonadotropin Release and the Effect of Opioid Blockade

Institutes of Endocrinology and Biochemistry (A.Bari.), Catholic University School of Medicine 00168 Rome, Italy

Address all correspondence and requests for reprints to: A. Barbarino, M.D., Institute of Endocrinology, Catholic University School of Medicine, Largo A. Gemelli 8, 00168 Rome, Italy.

We studied the inhibitory effect of exogenous CRH on pulsatile gonadotropin secretion and the role of endogenous opioid peptides in this phenomenon in normal women. To do so, we infused human CRH (100 µg/h for 3 h) into 15 normal women during the midluteal phase of their menstrual cycle and studied its effect on both basal (10 women) and GnRH-stimulated (5 women) plasma gonadotropin levels. CRH infusion induced a significant decrease in plasma LH and FSH levels in all women. The decline in plasma LH (62%) was greater than that in FSH (36%). Plasma LH and FSH concentrations returned to basal levels within 30 min after the end of the CRH infusion. CRH infusion did not alter the gonadotropin response to GnRH. We also infused naloxone plus CRH in the 10 women who had received CRH alone during the midluteal phase of a different cycle. Addition of naloxone to CRH (5 women) reversed the LH and FSH inhibition when naloxone was started 1 h after the start of the CRH infusion. When naloxone was started 1 h before CRH infusion (5 women), plasma LH and FSH concentrations did not change. Plasma cortisol increased similarly during both the CRH and CRH plus naloxone infusions; the mean cortisol levels at the end of the CRH and CRH plus naloxone infusions were 497 ± 40 (±SE) and 484 ± 41 nmol/L, respectively, compared to 240 ± 14 nmol/L after saline infusion (P < 0.001).

These results demonstrate that in normal women during the midluteal phase of the menstrual cycle, CRH inhibits the secretion of both LH and FSH. The CRH-induced inhibition of gonadotropin secretion is primarily mediated by endogenous opioid peptides, and this effect is not dependent on glucocorticoid levels. We suggest that the disruptive effect of stress on reproductive function in the women could be, at least in part, dependent on decreased gonadotropin secretion induced by elevated endogenous CRH levels.

Received July 12, 1988.

This article has been cited by other articles:

				A. Rickenlund, M. Thoren, K. Carlstrom, B. von Schoultz, and A. L. Hirschberg Diurnal Profiles of Testosterone and Pituitary Hormones Suggest Different Mechanisms for Menstrual Disturbances in Endurance Athletes J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 702 - 707. [Abstract] [Full Text] [PDF]

				J. Frias, J. M. Torres, M. T. Miranda, E. Ruiz, and E. Ortega EFFECTS OF ACUTE ALCOHOL INTOXICATION ON PITUITARY-GONADAL AXIS HORMONES, PITUITARY-ADRENAL AXIS HORMONES, {beta}-ENDORPHIN AND PROLACTIN IN HUMAN ADULTS OF BOTH SEXES Alcohol Alcohol., March 1, 2002; 37(2): 169 - 173. [Abstract] [Full Text] [PDF]

				J. A McLean, S. I Barr, and J. C Prior Cognitive dietary restraint is associated with higher urinary cortisol excretion in healthy premenopausal women Am. J. Clinical Nutrition, January 1, 2001; 73(1): 7 - 12. [Abstract] [Full Text] [PDF]

				R. M. Sapolsky, L. M. Romero, and A. U. Munck How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions Endocr. Rev., February 1, 2000; 21(1): 55 - 89. [Abstract] [Full Text]

				Corticotropin-Releasing Hormone: A Potent Androgen Secretagogue in Girls with Hyperandrogenism after Precocious Pubarche J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4602 - 4606. [Abstract] [Full Text]

				S. I Barr Vegetarianism and menstrual cycle disturbances: is there an association? Am. J. Clinical Nutrition, September 1, 1999; 70(3): 549S - 554. [Abstract] [Full Text] [PDF]

				M. Ferin Stress and the Reproductive Cycle J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1768 - 1774. [Full Text]

				J. Lado-Abeal, J. Rodriguez-Arnao, J. D. C. Newell-Price, L. A. Perry, A. B. Grossman, G. M. Besser, and P. J. Trainer Menstrual Abnormalities in Women with Cushing's Disease Are Correlated with Hypercortisolemia Rather Than Raised Circulating Androgen Levels J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3083 - 3088. [Abstract] [Full Text]

				J. Hangaard, M. Andersen, E. Grodum, O. Koldkjær, and C. Hagen Pulsatile Luteinizing Hormone Secretion in Patients with Addison's Disease. Impact of Glucocorticoid Substitution J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 736 - 743. [Abstract] [Full Text]

				D. A. Van Vugt, J. Piercy, A. E. Farley, R. L. Reid, and S. Rivest Luteinizing Hormone Secretion and Corticotropin-Releasing Factor Gene Expression in the Paraventricular Nucleus of Rhesus Monkeys Following Cortisol Synthesis Inhibition Endocrinology, June 1, 1997; 138(6): 2249 - 2258. [Abstract] [Full Text] [PDF]

				D. L. Metzger, J. R. Kerrigan, and A. D. Rogol The Short-Term Infusion of Ovine Corticotropin-Releasing Hormone Does Not Alter Luteinizing Hormone Concentrations in Young Adult Men J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 697 - 700. [Abstract] [Full Text] [PDF]